Bastide Le Confort Medical annual stock-based compensation
2021
2022
2023
2024
2025
Bastide Le Confort Medical Stock-Based Compensation Growth & History (BLC)
Bastide Le Confort Medical's stock-based compensation was €0 for fiscal 2025.
View full Bastide Le Confort Medical company overviewBastide Le Confort Medical annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | €0 | €0 | — |
| 2024 | 2024-06-30 | €0 | −€850,000 | — |
| 2023 | 2023-06-30 | €850,000 | €511,000 | +150.74% |
| 2022 | 2022-06-30 | €339,000 | −€44,000 | −11.49% |
| 2021 | 2021-06-30 | €383,000 | — | — |
Bastide Le Confort Medical stock-based compensation trends
Between the periods ended 2021-06-30 and 2025-06-30, Bastide Le Confort Medical's stock-based compensation decreased from €383,000 to €0, a change of −€383,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
reported stock-based compensation
TickerStat standardizes share-based compensation reported in company official filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bastide Le Confort Medical source filings ↗